I am not sure that "100% healed" can be guaranteed from this announcement but it is indeed good news and we can look forward to November. The vast majority of the data indicates we are onto a good thing. The abandoned ECM process and Vitrogro fiasco from 2015 has meant this treatment has taken so much longer to get to this stage than it needed to if properly managed. Whilst I have accumulated on the slide I am sorry for all those sufferers that should now be using this product had it hit the market when anticipated.
Hopefully we now see the positive results of the treatment and hope it gives relief many of the sufferers of venous ulcers.
- Forums
- ASX - By Stock
- Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial
I am not sure that "100% healed" can be guaranteed from this...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online